Full Press Release Details
Biogen Idec and Knopp Neurosciences Announce License Agreement for Late-Stage ALS Drug Candidate.
BIIB
Biogen Idec and Knopp Neurosciences Announce License Agreement for Late-Stage ALS Drug Candidate
Key Takeaway: Biogen Idec and Knopp Neurosciences Announce License Agreement for Late-Stage ALS Drug Candidate